CAS: 96068-42-7
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol REF: 3D-WDA06842CAS: 96068-42-7 | Min. 95% | 180,00 €~746,00 € | Do 13 Feb 25 |
 | SARS-CoV-2-IN-32 REF: TM-T63181CAS: 96068-42-7 | - - - | 2.023,00 €~3.328,00 € | Do 27 Feb 25 |
4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol
CAS:96068-42-7
Please enquire for more information about 4-((5-hydroxy-3-methyl-1-phenylpyrazol-4-yl)(4-nitrophenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol including the price, delivery time and more detailed …
Formel:
C27H23N5O4
Reinheit:
Min. 95%
Molekulargewicht:
481.5 g/mol
Ref: 3D-WDA06842
| 10mg | 180,00 € | ||
| 25mg | 230,00 € | ||
| 50mg | 340,00 € | ||
| 100mg | 498,00 € | ||
| 250mg | 746,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 13. Februar 2025
SARS-CoV-2-IN-32
CAS:96068-42-7
SARS-CoV-2-IN-32 inhibits COVID-19 (Mpro; PDB: 6LU7) and has anti-cancer effects; useful for related research.
Formel:
C27H23N5O4
Farbe und Form:
Liquid
Molekulargewicht:
481.5
Ref: TM-T63181
| 25mg | 2.023,00 € | ||
| 50mg | 2.633,00 € | ||
| 100mg | 3.328,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 27. Februar 2025
